Mortality and metformin use in patients with advanced chronic kidney disease--Authors' reply

Lancet Diabetes Endocrinol. 2015 Sep;3(9):681. doi: 10.1016/S2213-8587(15)00287-9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / mortality*
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Metformin / adverse effects*
  • Renal Insufficiency, Chronic / complications*
  • Renal Insufficiency, Chronic / mortality*

Substances

  • Hypoglycemic Agents
  • Metformin